🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
30.20
-2.34 (-7.19%)
Nov 20, 2026, 4:00 PM EST - Market closed

Nektar Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
34.6915.1244.2535.2888.2325.22
Short-Term Investments
579.67230.64210.97268.34416.75708.74
Cash & Short-Term Investments
614.36245.75255.23303.62504.98733.96
Cash Growth
127.36%-3.71%-15.94%-39.88%-31.20%-30.88%
Accounts Receivable
---1.215.9822.49
Other Receivables
6.131.781.611.052.421.4
Receivables
6.131.781.612.258.423.89
Inventory
---16.119.215.8
Prepaid Expenses
2.882.22.514.415.99-
Other Current Assets
55.9716.541.954.337.421.93
Total Current Assets
679.33266.27261.29330.7545.97795.58
Property, Plant & Equipment
-511.8236.8685.89177.54
Long-Term Investments
338.53.4926.0925.83-64.83
Goodwill
----76.576.5
Other Long-Term Assets
19.425.654.654.642.252.74
Total Assets
1,037280.41303.85398.03710.61,117

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
18.1310.7711.569.8512.989.75
Accrued Expenses
31.7719.6427.2119.1428.8558.01
Current Portion of Leases
22.8820.519.8719.2618.6717.44
Other Current Liabilities
2.692.632.773.027.71-
Total Current Liabilities
75.4853.5461.451.2768.285.2
Long-Term Debt
54.7963.1691.78112.63155.38195.43
Long-Term Leases
5165.2682.798.52112.83125.74
Other Long-Term Liabilities
6.278.637.244.647.5531.32
Total Liabilities
187.53190.57243.11267.05343.96437.68

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0000.020.020.02
Additional Paid-In Capital
4,7553,8503,6603,6083,5753,517
Retained Earnings
-3,901-3,760-3,596-3,477-3,201-2,833
Treasury Stock
---3---
Comprehensive Income & Other
-3.950.020.060.08-6.91-4.16
Shareholders' Equity
849.7289.8360.74130.99366.64679.51
Total Liabilities & Equity
1,037280.41303.85398.03710.61,117

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
128.67148.91194.34230.4286.87338.6
Net Cash (Debt)
824.1996.8474.7699.04218.1460.18
Net Cash Growth
699.18%29.55%-24.52%-54.59%-52.61%-45.73%
Net Cash Per Share
29.335.745.457.8217.4837.66
Filing Date Shares Outstanding
34.2128.6912.4112.2412.6212.42
Total Common Shares Outstanding
34.2120.3812.3912.7612.5712.36
Working Capital
603.86212.73199.89279.43477.76710.38
Book Value Per Share
24.844.414.9010.2729.1754.96
Tangible Book Value
849.7289.8360.74130.99290.14603.01
Tangible Book Value Per Share
24.844.414.9010.2723.0848.77
Buildings
---43.1874.8997.39
Machinery
---61.8379.76104
Construction In Progress
---0.742.537.16
SEC Filings: 10-K · 10-Q